BRAF and colorectal carcinoma: Our results that there have been no vital association between prevalence of BRAF mutation and the patient gender (p > 0.05) is incontestable, with similar results demonstrated by Cardarella et al. [25], Ilie et al. [17], and Chen et al. [20] Such association was previously observed in female patients with BRAF mutant colorectal carcinoma [26, 27].